Cargando…
IL-33 blockade suppresses tumor growth of human lung cancer through direct and indirect pathways in a preclinical model
Non-small-cell lung cancer (NSCLC) is the most common type in lung cancer, a leading cause of cancer-related death worldwide. Our previous study unraveled a pro-cancer function of IL-33 in fueling outgrowth and metastasis of human NSCLC cells. Herein, we determined that interfere with IL-33 activity...
Autores principales: | Wang, Kailing, Shan, Shan, Yang, Zongjun, Gu, Xia, Wang, Yuanyuan, Wang, Chunhong, Ren, Tao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5620278/ https://www.ncbi.nlm.nih.gov/pubmed/28978138 http://dx.doi.org/10.18632/oncotarget.19786 |
Ejemplares similares
-
Blockade of IL‐33 signalling attenuates osteoarthritis
por: He, Zengliang, et al.
Publicado: (2020) -
Tristetraprolin inhibits gastric cancer progression through suppression of IL-33
por: Deng, Kaiyuan, et al.
Publicado: (2016) -
The stimulatory activity of plasma in patients with advanced non-small cell lung cancer requires TLR-stimulating nucleic acid immunoglobulin complexes and discriminates responsiveness to chemotherapy
por: Xu, Zengguang, et al.
Publicado: (2014) -
IL-33 reflects dynamics of disease activity in patients with autoimmune hemolytic anemia by regulating autoantibody production
por: Bu, Xiangmao, et al.
Publicado: (2015) -
IL-33 Participates in the Development of Esophageal Adenocarcinoma
por: Liu, Jia, et al.
Publicado: (2022)